Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalomid and Carboplatin for Pediatric Brain Stem Glioma
NCT00179881Phase 2Completed
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Dec 1999
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of thalidomide in brainstem glioma (2 arms), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Primary endpoints: Overall Survival, Event Free Survival and 2 more. Started Dec 1999; status: completed.
02
Drugs
thalidomide
03
Conditions
brainstem glioma
Beyond the preview
Go deeper on NCT00179881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179881.